What are Travere Therapeutics, Inc.'s profit margins?

Travere Therapeutics, Inc. (TVTX) runs a 98.6% gross margin and a -10.6% operating margin, with a -20.3% net margin.

Where do Travere Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Travere Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Travere Therapeutics, Inc. TVTX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	98.6%+0.7pp	97.9%+0.3pp	97.6%+0.7pp	96.9%+0.9pp	96%-0.7pp
Operating margin	-10.6%+2.2pp	-12.8%+8.1pp	-20.9%+30.7pp	-51.6%+31.5pp	-83.1%+55.8pp
EBITDA margin	3%+3.4pp	-0.4%+7.9pp	-8.4%+28.2pp	-36.6%+29.5pp	-66.1%+54.1pp
Returns
Return on invested capital	-118%-21.9pp	-96.2%—	——	-636.6%-251pp	-385.6%-138pp
Efficiency
Asset turnover	1×+0.2×	0.8×0.0×	0.8×+0.2×	0.6×+0.2×	0.5×+0.1×
Inventory turnover	0.2×-0.1×	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×+0.1×
Liquidity
Current ratio	3.1×+0.4×	2.7×0.0×	2.7×+0.7×	2×0.0×	2.1×0.0×
Quick ratio	2.9×+0.3×	2.5×0.0×	2.5×+0.7×	1.8×0.0×	1.9×0.0×
Cash ratio	0.6×0.0×	0.6×-0.2×	0.8×+0.4×	0.4×+0.1×	0.3×0.0×
Leverage
Debt-to-equity	0.2×0.0×	0.1×-0.1×	0.2×-2.5×	2.7×0.0×	2.7×+1.2×
Debt-to-assets	0×0.0×	0×0.0×	0×-0.1×	0.2×0.0×	0.2×0.0×
Net debt / EBITDA	-3.9×—	——	——	——	——
Interest coverage	-5.6×+0.2×	-5.8×+2.2×	-8.1×+7.2×	-15.2×+5.0×	-20.2×+8.7×
Per Share
Book value per share	$1.07-16.5%	$1.29+79.5%	$0.72+94.7%	$0.37-0.9%	$0.37-50.4%
Valuation
Market capitalization	$2.74B-19.8%	$3.42B+60.5%	$2.13B+57.4%	$1.35B-14.9%	$1.59B+4.9%
Enterprise value	$2.68B-19.9%	$3.34B+64.0%	$2.04B+49.1%	$1.37B-15.5%	$1.62B+4.5%
Price / sales	5.1×-1.9×	7×+2.1×	4.9×+0.8×	4.1×-1.8×	5.8×-0.7×
Price / book	27.8×-2.0×	29.8×+0.8×	29×-12.4×	41.3×-7.1×	48.4×+22.8×
EV / EBITDA	166.4×—	——	——	——	——
EV / sales	5×-1.8×	6.8×+2.1×	4.7×+0.6×	4.1×-1.8×	5.9×-0.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Travere Therapeutics, Inc.'s profit margins?: Travere Therapeutics, Inc. (TVTX) runs a 98.6% gross margin and a -10.6% operating margin, with a -20.3% net margin.
Where do Travere Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Travere Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.